U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Insulin-resistant diabetes mellitus AND acanthosis nigricans

MedGen UID:
501111
Concept ID:
C0342278
Disease or Syndrome
Synonyms: Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans; DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS, TYPE A; INSULIN RECEPTOR, DEFECT IN, WITH INSULIN-RESISTANT DIABETES MELLITUS AND ACANTHOSIS NIGRICANS; Insulin-resistance syndrome type A; IRAN, TYPE A; type A insulin resistance
SNOMED CT: Hereditary benign acanthosis nigricans with insulin resistance (237606005); Insulin-resistant acanthosis nigricans type A (237606005); Insulin receptor defect with insulin-resistant diabetes mellitus and acanthosis nigricans (237606005)
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Gene (location): INSR (19p13.2)
 
Monarch Initiative: MONDO:0012520
OMIM®: 610549
Orphanet: ORPHA2297

Definition

Type A insulin resistance syndrome is a rare disorder characterized by severe insulin resistance, a condition in which the body's tissues and organs do not respond properly to the hormone insulin. Insulin normally helps regulate blood sugar levels by controlling how much sugar (in the form of glucose) is passed from the bloodstream into cells to be used as energy. In people with type A insulin resistance syndrome, insulin resistance impairs blood glucose regulation and ultimately leads to a condition called diabetes mellitus, in which blood glucose levels can become dangerously high.

Severe insulin resistance also underlies the other signs and symptoms of type A insulin resistance syndrome. In affected females, the major features of the condition become apparent in adolescence. Many affected females do not begin menstruation by age 16 (primary amenorrhea) or their periods may be light and irregular (oligomenorrhea). They develop cysts on the ovaries and excessive body hair growth (hirsutism). Most affected females also develop a skin condition called acanthosis nigricans, in which the skin in body folds and creases becomes thick, dark, and velvety. Unlike most people with insulin resistance, females with type A insulin resistance syndrome are usually not overweight.

The features of type A insulin resistance syndrome are more subtle in affected males. Some males have low blood glucose (hypoglycemia) as the only sign; others may also have acanthosis nigricans. In many cases, males with this condition come to medical attention only when they develop diabetes mellitus in adulthood.

Type A insulin resistance syndrome is one of a group of related conditions described as inherited severe insulin resistance syndromes. These disorders, which also include Donohue syndrome and Rabson-Mendenhall syndrome, are considered part of a spectrum. Type A insulin resistance syndrome represents the mildest end of the spectrum: its features often do not become apparent until puberty or later, and it is generally not life-threatening. [from MedlinePlus Genetics]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVInsulin-resistant diabetes mellitus AND acanthosis nigricans

Professional guidelines

PubMed

Hermanns-Lê T, Scheen A, Piérard GE
Am J Clin Dermatol 2004;5(3):199-203. doi: 10.2165/00128071-200405030-00008. PMID: 15186199
Gungor N, Arslanian S
Treat Endocrinol 2002;1(6):359-71. doi: 10.2165/00024677-200201060-00002. PMID: 15832489
Minchoff LE, Grandin JA
Nurse Pract 1996 Jun;21(6):74-5, 79-80, 83-6. PMID: 8784876

Recent clinical studies

Diagnosis

Quecedo E, Febrer I, Serrano G, Martinez-Aparicio A, Aliaga A
Pediatr Dermatol 1996 Nov-Dec;13(6):477-82. doi: 10.1111/j.1525-1470.1996.tb00728.x. PMID: 8987057

Therapy

Quecedo E, Febrer I, Serrano G, Martinez-Aparicio A, Aliaga A
Pediatr Dermatol 1996 Nov-Dec;13(6):477-82. doi: 10.1111/j.1525-1470.1996.tb00728.x. PMID: 8987057

Clinical prediction guides

Quecedo E, Febrer I, Serrano G, Martinez-Aparicio A, Aliaga A
Pediatr Dermatol 1996 Nov-Dec;13(6):477-82. doi: 10.1111/j.1525-1470.1996.tb00728.x. PMID: 8987057

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...